GlassScriptPhysician profile
Justin Houman
NPI 1053794016
$32,681.97
in general payments reported to CMS, 2019-2025
43 companies · $2,477 in 2025
The $2,477 reported for 2025 was more than what 84% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,120 · 2020: $2,036 · 2021: $2,576 · 2022: $7,938 · 2023: $4,497 · 2024: $9,037 · 2025: $2,477.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $9,045 · Food and Beverage: $5,364 · Honoraria: $1,104 · Consulting Fee: $420 · Education: $77.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $9,045.00 |
| Food and Beverage | $5,364.12 |
| Honoraria | $1,104.00 |
| Consulting Fee | $420.00 |
| Education | $77.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $16,613.41 | 2019-2025 | Ams 700 Cxr Rte Kit, Ams 700, Tactra |
| Endo Pharmaceuticals INC. | $5,816.42 | 2020-2023 | Xiaflex |
| Abbvie INC. | $1,210.42 | 2020-2025 | |
| Cook Incorporated | $900.00 | 2024-2025 | |
| C. R. Bard, INC. & Subsidiaries | $719.00 | 2021-2024 | |
| Genzyme Corporation | $700.00 | 2020 | |
| Medtronic, INC. | $695.11 | 2021-2025 | Interstim |
| Urogen Pharma, INC. | $607.97 | 2022-2023 | Jelmyto |
| Sumitomo Pharma America, INC. | $435.21 | 2023-2025 | Orgovyx, Gemtesa |
| Endo USA, INC. | $420.00 | 2025 | |
| Dendreon Pharmaceuticals LLC | $382.64 | 2021-2024 | Provenge |
| Antares Pharma, INC. | $376.16 | 2019-2022 | |
| Coloplast Corp | $372.93 | 2021-2024 | Titan |
| Axonics, INC. | $291.45 | 2022-2024 | Axonics |
| Astellas Pharma US INC | $274.15 | 2020-2025 | Xtandi |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $250.58 | 2021-2023 | Prolaris |
| Teleflex LLC | $249.34 | 2021-2022 | |
| Pfizer INC. | $238.95 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $189.17 | 2021-2025 | Keytruda, Lynparza, Welireg |
| Calyxo, INC. | $180.95 | 2025 | Cvac Aspiration System |
| Laborie Medical Technologies Corp. | $174.26 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Medtronic USA, INC. | $168.22 | 2019 | |
| Blue Earth Diagnostics | $153.43 | 2021-2025 | Posluma |
| Mimedx Group, INC. | $150.00 | 2025 | |
| Heartflow, INC. | $148.28 | 2022 | |
| Ferring Pharmaceuticals INC. | $147.20 | 2024-2025 | Adstiladrin |
| Telix Pharmaceuticals | $118.36 | 2024-2025 | Illuccix |
| Bayer Healthcare Pharmaceuticals INC. | $113.02 | 2021-2024 | |
| Janssen Biotech, INC. | $106.45 | 2021-2025 | Erleada |
| Dornier Medtech America, INC | $102.06 | 2025 | Dornier Medtech |
| Profound Medical Corp. | $88.19 | 2023 | Tulsa-Pro |
| Myovant Sciences INC. | $51.10 | 2022 | |
| Immunitybio, INC. | $41.76 | 2024-2025 | |
| Rigicon,INC. | $28.03 | 2023 | Rigi10 Malleable Penile Prosthesis |
| Ethicon US, LLC | $25.78 | 2021 | |
| Progenics Pharmaceuticals, INC. | $23.03 | 2025 | |
| Urovant Sciences INC | $20.29 | 2022 | |
| Dentsply Ih INC. | $18.05 | 2022 | |
| Hollister Incorporated | $17.29 | 2024 | Vapro |
| Abc Home Medical Supply, INC. | $17.29 | 2024 | |
| Tolmar, INC. | $16.95 | 2023 | |
| Becton, Dickinson and Company | $15.00 | 2025 | Bard X-Force Balloon Dilation Catheter |
| Dentsply Ih Ab | $14.07 | 2025 | Lofric |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Houman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.